Neuberger Berman Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,000
Closed -$2.01M – 2291
2026
Q2
$2.01M Buy
+8,000
New +$1.72M ﹤0.01% 1292

Other funds holding ABBV

Neuberger Berman Group's ABBV Position: Q3 2026 in Review

Neuberger Berman Group increased its AbbVie (ABBV) stake by 44% in Q3 2026, buying an estimated $146M and bringing the position to 1,848,306 shares worth $484M. The position accounts for 0.33% of the portfolio, ranked #55.

Neuberger Berman Group first reported a position in ABBV in Q2 2013 and has held it in 54 quarters since. The position peaked at $490M in Q4 2023. 4,258 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Neuberger Berman Group held 1,848,306 shares of AbbVie worth $484M as of Q3 2026.
  • Neuberger Berman Group bought 569,131 AbbVie shares in Q3 2026, an estimated $146M.
  • AbbVie made up 0.33% of Neuberger Berman Group's portfolio in Q3 2026, its #55 holding.
  • Neuberger Berman Group first reported a position in AbbVie in Q2 2013 and has held it in 54 quarters since.
  • Neuberger Berman Group's AbbVie position peaked at $490M in Q4 2023.
  • 4,258 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.